Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of APL180

Summary

The design of this study will enable an extensive evaluation of safety, tolerability, and PK-PD relationship following 4 weeks of dosing in patients with Coronary heart Disease

Timeline

Start

2009-06

Primary completion

2009-10

Completion

—

Drugs

Indications